Results 161 to 170 of about 1,018 (177)
Some of the next articles are maybe not open access.
Structure of Cruzipain/Cruzain Inhibitors Isolated from Bauhinia bauhinioides Seeds
bchm, 2001The saline extract of Bauhinia bauhinioides dry seeds was shown to inhibit cruzipain, a cysteine proteinase from Trypanosoma cruzi. The inhibitory activity was assigned to a protein with 164 amino acid residues and molecular mass of 18 034 Da that was purified by chromatography on DEAE-Sephadex, trypsin-Sepharose (removal of trypsin inhibitors), Mono Q
C, de Oliveira +6 more
openaire +2 more sources
Discovery of Novel Inhibitors of Cruzain Cysteine Protease of Trypanosoma cruzi
Current Medicinal ChemistryAbstract: Chagas disease (CD) is a parasitic disease endemic in several developing coun-tries. According to the World Health Organization, approximately 6-8 million people worldwide are inflicted by CD. The scarcity of new drugs, mainly for the chronic phase, is the main reason for treatment limitation in CD.
João Lucas Bruno Prates +5 more
openaire +2 more sources
Computational Study of the Catalytic Mechanism of the Cruzain Cysteine Protease
ACS Catalysis, 2017Cysteine proteases of the papain family are involved in many diseases, making them attractive targets for developing drugs. In this paper, different catalytic mechanisms of cruzain cysteine protease have been studied on the basis of molecular dynamics simulations within hybrid quantum mechanics/molecular mechanics potentials.
Kemel Arafet +2 more
openaire +1 more source
Integration of Ligand‐ and Target‐Based Virtual Screening for the Discovery of Cruzain Inhibitors
Molecular Informatics, 2011AbstractA myriad of methods are available for virtual screening of small organic compound databases. In this study we have successfully applied a quantitative model of consensus measurements, using a combination of 3D similarity searches (ROCS and EON), Hologram Quantitative Structure Activity Relationships (HQSAR) and docking (FRED, FlexX, Glide and ...
H J, Wiggers +3 more
openaire +2 more sources
Structure-based discovery of novel cruzain inhibitors with distinct trypanocidal activity profiles
European Journal of Medicinal Chemistry, 2023Viviane Correa Santos +2 more
exaly
Screening the Pathogen Box to Discover and Characterize New Cruzain and TbrCatL Inhibitors
Pathogens, 2023Luan Carvalho Martins +2 more
exaly

